Searchable abstracts of presentations at key conferences in endocrinology

ea0011p165 | Clinical case reports | ECE2006

Metformin-associated lactic acidosis in a caucasian woman precipitated by acute renal failure treated with bicarbonate haemodialysis

González Losada T , Del Olmo García L , Martinez de Icaya P , Alcázar Lázaro V , López del Val T , Pérez Pelayo M , Herranz Antolín S

Clinical case: A 51 year-old caucasian woman was admitted in the emergency room of our hospital with psicomotor agitation and confusion after four days of a profuse watery diarrhea, with 5 stools per day, abdominal cramps and vomiting. She started 500 mg of aspirin on her own initiative. Her medical profile included a type 2 diabetes treated with metformin 850 mg/12 hours and glyburide 7.5 mg/day, and hypertension treated with enalapril 20 mg/day. No renal imparement was docum...

ea0011p586 | Neuroendocrinology and behaviour | ECE2006

Clinical significance of macroprolactin

Álvarez-Vázquez P , Rodríguez Pérez D , Álvarez García E , Páramo Fernandez C , Hervás Abad E , Andrade Olivié MA

Introduction: Macroprolactin (maPRL) is a high molecular weight variant of prolactin (PRL) which has reduced bioactivity. The purpose of the present study was to determine the clinic-analytical repercussion of the presence of maPRL in patients with hyperprolactinaemia.Patients and methods: A polyethylene glycol (PEG) precipitation test was used to detect the presence of maPRL in all consecutive samples with prolactin levels >50 ng/ml (1060 mUIL). A r...

ea0073oc8.3 | Oral Communications 8: Pituitary and Neuroendocrinology | ECE2021

GFRα2 as a GPS marker: Role of GFRα2 in pituitary gland

Pradilla Dieste Alberto , García Lavandeira Montserrat , Pérez-Romero Sihara , Graça Fonseca Jesuina Arcángela , Kupari Jussi , Japón Miguel , Airaksinen Matti S. , Álvarez Clara V.

The pituitary gland is the master gland of the endocrine system, controlling important physiological steps like growth, puberty or reproduction. There are different endocrine cell types within the adenopituitary, each one producing a specific hormone. Adaptation to different life stages and moments requires a plastic capacity based in proliferation and differentiation of pituitary stem cells. We ans others discovered the existence of a stem cell niche in the pituitary. Parench...

ea0073aep165 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Circulating microRNAs as predictive tool of the effectiveness of lifestyle intervention for weight loss

Clemente-Postigo Mercedes , Coin-Araguez Leticia , Jose Carlos Fernández-García , Alcaide-Torres Juan A , Bekay Rajaa El , Bernal-Lopez Maria Rosa , Macias-Gonzalez Manuel , Tinahones Francisco J

Background and aimsLifestyle modifications based on diet and exercise are common strategies for the treatment and prevention of obesity and related comorbidities. However, not all patients respond equally to similar weight loss intervention which compromise patient adherence. Strategies for predicting the individual response are required for improving intervention efficiency by personalized recommendations. microRNAs (miRNAs), small RNA particles which r...

ea0073aep381 | Endocrine-Related Cancer | ECE2021

Case report: Secondary adrenal insufficiency and primary hypothyroidism following Nivolumab therapy in a patient with metastatic melanoma

Paloma González Lázaro , Tirado Antonio Moreno , Pascual Cristina Contreras , Mendez Cristina Montalban , María Zhao Montero Benítez , Inés Gómez García

IntroductionIn recent years, we have observed significant progress in cancer treatment associated with the development of immunotherapy. Nivolumab, an anti-PD-1 antibody, blocks the interaction between PD-1 and its ligands and inhibits the signaling pathway by preventing the tumor-derived PD-L1 from blocking T lymphocytes. In patients with metastatic melanoma, it is used either in monotherapy or in combination with other drugs. Immunotherapy is associate...

ea0073aep504 | Pituitary and Neuroendocrinology | ECE2021

Acromegaly: Knowing the enemy in order to win

Porras Mariana Gomes , Alexa Benítez Valderrama , Paola Parra Ramírez , Rosa García Moreno , Rojas Patricia Martin , Gumersindo Fernández Vázquez , Beatriz Lecumberri Santamaría , Cristina Álvarez Escolá

IntroductionAcromegaly is an uncommon chronic disease with an insidious course. Due to the high morbimortality it causes, its early diagnosis and treatment are priority. The three therapeutic pillars are surgery, pharmacological treatment and radiotherapy, alone or in combination.ObjectivesTo clinically, biochemically and histologically characterize patients with acromegaly under follow-up in a tertiary hospi...

ea0073aep828 | Late Breaking | ECE2021

Duodenal neuroendocrine tumor (siNET) and Rothmund-Thomson syndrome: a new association of a rare genetic disorder

Paja Fano Miguel , Adela L. Martínez-Martínez , Andoni Monzón , Josune Rodríguez-Soto , Merlo Ignacio , María J García-Barcina , Merino Sonia , M. Carmen González-Serrano

Rothmund-Thomson syndrome (RTS) usually presents with physical stigmata (poikiloderma, ectodermal dysplasia, juvenile cataracts…) and it´s associated with malignancies in patients with homozygous or compound heterozygous mutations in the RECQL4 helicase gene (RTS-II). Neoplasms include osteosarcoma in childhood and skin cancer later in life, with occasional malignancies affecting other tissues (leukemia, lymphoma and gastrointestinal adenocarcinomas). To ou...

ea0073ep152 | Pituitary and Neuroendocrinology | ECE2021

Management of malignant insulina

Nerea Egaña Zunzunegui , Elias Ortega Cristina , Venegas Nebreda Inmaculada , Bilbao Garay Ismene , Aramburu Calafell Maite , Cristina García Delgado , Rojo Alvaro Jorge , Maite Perez de Ciriza Cordeu , Yoldi Arrieta Alfredo , Miguel Maria Goena Iglesias

IntroductionMalignant insulinoma is a rare pancreatic neuroendocrine tumor that accounts for only 10% of all cases of insulinoma. The clinical picture is characterized by the presence of severe hyperinsulinemic hypoglycaemic syndrome in a patient with pancreatic tumor with locoregional and/or distant metastases. Therapeutic management is challenging due to the need to control both hypoglycemic syndrome and tumor growth. Curative surgery is rarely applica...

ea0070aep654 | Pituitary and Neuroendocrinology | ECE2020

Our experience with lu-dotatate in patients with neuroendocrine tumors in a tertiary hospital

Munoz Diego , Carlos Percovich Hualpa Juan , Weber Bettina , Atencia Goñi José , González Fernández Laura , Miguélez González María , Brox Torrecilla Noemí , José Añez Ramos Roberto , Maricel Rivas Montenegro Alejandra , López Guerra Aurelio , Lucía Olmedilla Isishi Yoko , Ángeles Vélez Romero María , Ágreda García Javier , Picallo Pérez María , Monereo Megías Susana , García Centeno Rogelio

Introduction: Lutetium-177-DOTATATE (Lu177) is approved in patients with well-differentiated (G1 and G2) neuroendocrine tumors (NETs) positive to somatostatin receptors, progressive and unresectable or metastatic. Lu177 has been shown to increase progression-free survival and the quality of life of these patients.Material and Methods: Retrospective descriptive study of a series of 15 cases with NETs treated with Lu177. Demographic data, tumor characteris...

ea0073aep252 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Inhibition of ATG3 ameliorates liver steatosis by increasing SIRT1 in an autophagic-independent action

Novoa Eva , Nátalia da Silva Lima , Marcos Férnandez Fondevila , Buque Xabier , María Jesús González Rellán , Uxía Fernández Paz , María García Vence , María del Pilar Chantada Vázquez , Bravo Susana , Patricia Marañon , Escudero Adriana , Leiva Magdalena , Fidalgo Miguel , Gomes Pedro , Claret Marc , Sabio Guadalupe , Rey Marta Varela , Delgado Teresa , Miguel López , Carlos Diéguez , María Martínez Chantar , Carmelo García Monzon , Agueda González Rodríguez , Aspichueta Patricia , Rubén Nogueiras Pozo

Background and aimsNonalcoholic fatty liver disease (NAFLD) is a major health threat in both developed and developing countries and is a precursor of the more advanced liver diseases including nonalcoholic steatohepatitis (NASH), liver cirrhosis and liver cancer. One of the numerous molecules participating in the development of liver steatosis is p63. Although p63 is mainly known for its roles as a tumor suppressor and cell maintenance and renewal, we ha...